Point-of-Care Testing
News on technologies and applications for point-of-care testing.
The firm received FDA 510(k) clearance late last year for its 10-minute blood-based test that stratifies patients by their risk of developing sepsis.
DiaSorin, MeMed Ink Italian Distribution Deal for Test to Differentiate Bacterial, Viral Infection
The partnership enables DiaSorin to distribute the MeMed BV test on the Liaison XL and XS as well as on the MeMed Key point-of-need system.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
AmplifiDx Gets $1.4M NIH RADx Grant for Point-of-Care Molecular Testing Instrument
The Massachusetts-based firm plans to use the funding toward development of its nucleic acid amplification test platform and multiplex respiratory test.
The startup is looking to close a $9 million Series A round in Q3 and launch the system and a strep A assay in 2024.